FSPTX | PGKCX | FSPTX / PGKCX | |
Total Expense Ratio | 0.62 | 1.85 | 34% |
Annual Report Gross Expense Ratio | 0.62 | 3.01 | 21% |
Fund Existence | 44 years | 7 years | - |
Gain YTD | 4.555 | 4.432 | 103% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 17.3B | 39.4M | 43,909% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 5.41 | 2.33 | 233% |
Returns for 3 years | 108.46 | 116.49 | 93% |
Returns for 5 years | 65.16 | 72.15 | 90% |
Returns for 10 years | 224.04 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BIB | 48.34 | 0.43 | +0.90% |
ProShares Ultra Nasdaq Biotechnology | |||
CGDV | 40.18 | 0.33 | +0.83% |
Capital Group Dividend Value ETF | |||
SMLV | 129.56 | 1.02 | +0.80% |
SPDR® SSGA US Small Cap Low Volatil ETF | |||
CHI | 10.58 | 0.03 | +0.28% |
Calamos Convertible Opportunities and Income Fund | |||
MDEV | 20.48 | N/A | N/A |
First Trust Indxx Global Mdcl Dvcs ETF |